147 research outputs found
Coccidioidomycosis: Medical and Spatio-Temporal Perspectives
Coccidioidomycosis (CM) is a disease of major public health importance due to the challenges in its diagnosis and treatment. To understand CM requires the attributes of a multidisciplinary network analysis to appreciate the complexity of the medical, the environmental and the social issues involved: public health, public policy, geology, atmospheric science, agronomy, social sciences and finally humanities, all which provide insight into this population transformation.In section 1 of this paper, we describe the CM-epidemiology, the clinical features, the diagnosis and finally the treatment.In section 2, we highlight the most important contributions and controversies in the history of the CM-research by using scientometric or bibliometric evaluations of research that are based on Garfield’s work (Garfield.library.upenn.edu) on the propagation of scientific thinking
Coccidioidomycosis: Medical and Spatio-Temporal Perspectives
Coccidioidomycosis (CM) is a disease of major public health importance due to the challenges in its diagnosis and treatment. To understand CM requires the attributes of a multidisciplinary network analysis to appreciate the complexity of the medical, the environmental and the social issues involved: public health, public policy, geology, atmospheric science, agronomy, social sciences and finally humanities, all which provide insight into this population transformation.
In section 1 of this paper, we describe the CM-epidemiology, the clinical features, the diagnosis and finally the treatment.
In section 2, we highlight the most important contributions and controversies in the history of the CM-research by using scientometric or bibliometric evaluations of research that are based on Garfield’s work (Garfield.library.upenn.edu) on the propagation of scientific thinking
Interdisciplinary Science to Confront Coccidioidomycosis
The long journey of research to lower risks of Coccidioidomycosis (CM) began in the late 19th century in Argentina and continued north to Mexico, the US and other countries. During this trip, medical science led the way. Although interdisciplinary research is not alien to medical science, e.g. geographic epidemiology, interaction with other disciplines has been low priority. This paper argues that the efficacy of CM mitigation and treatment can be improved through multi- and inter-disciplinary information exchange, particularly with earth and environmental sciences. Greater interaction and open publication practice are essential. Section 1 describes CM-epidemiology, the clinical features, the diagnosis and finally, the treatment.Section 2 discusses epidemiological evidence for atmospheric influence on cases of CM.Section 3 highlights the most important contributions and controversies in the history of CM-research through scientometric or bibliometric evaluations of research that are based on Garfield’s work on the propagation of scientific thinking.
Candida glabrata’s recurrent infections: biofilm formation during Amphotericin B treatment
Candida species are responsible for recurrent human infections, mostly in immunocompromised patients, due to their high vulnerability. Candida glabrata has a major role in systemic candidiasis and Amphotericin B (AmB), a hospital environment exclusive polyene, is frequently used to treat this disease. Lately, however, clinical evidences of Candida recurrent infections during these treatments are being described, probably due to biofilms (re)formation during this therapy.
Thus, this work aims at inferring if C. glabrata biofilms are still being formed during AmB treatment.
For that, C. glabrata biofilms were formed in the presence of AmB and analysed by dry weight. Matrix composition was analysed quantifying carbohydrates and, specifically, -1,3 glucans.
Results demonstrated that, although in a lesser extent, C. glabrata is able to develop biofilms in the presence of AmB, with a thick extracellular matrix, with an increase on carbohydrates, especially -1,3 glucans. Therefore, it is confirmed that complex biofilms of C. glabrata can be formed during an AmB treatment.This work was supported by the Programa Operacional,
Fatores de competitividade – COMPETE and by national
funds through FCT – Fundação para a Ciência e a Tecnologia
on the scope of the projects FCT PTDC/SAUMIC/119069/2010,
RECI/EBB-EBI/0179/2012, PEst-OE/
EQB/LA0023/2013 and C elia F. Rodrigues’ SFRH/BD/
93078/2013 PhD grant. The authors thank the Project
‘BioHealth - Biotechnology and Bioengineering approaches
to improve health quality’, Ref. NORTE-07-0124-FEDER-
000027, co-funded by the Programa Operacional Regional
do Norte (ON.2 – O Novo Norte), QREN, FEDER
Latent Tuberculosis among Persons at Risk for Infection with HIV, Tijuana, Mexico
Interventions that prevent HIV transmission and TB reactivation are needed
Performance of the G4 Xpert(R) MTB/RIF assay for the detection of Mycobacterium tuberculosis and rifampin resistance: a retrospective case-control study of analytical and clinical samples from high- and low-tuberculosis prevalence settings
BACKGROUND: The Xpert(R) MTB/RIF (Xpert) assay is a rapid PCR-based assay for the detection of Mycobacterium tuberculosis complex DNA (MTBc) and mutations associated with rifampin resistance (RIF). An updated version introduced in 2011, the G4 Xpert, included modifications to probe B and updated analytic software.
METHODS: An analytical study was performed to assess Xpert detection of mutations associated with rifampin resistance in rifampin-susceptible and -resistant isolates. A clinical study was performed in which specimens from US and non-US persons suspected of tuberculosis (TB) were tested to determine Xpert performance characteristics. All specimens underwent smear microscopy, mycobacterial culture, conventional drug-susceptibility testing and Xpert testing; DNA from isolates with discordant rifampin resistance results was sequenced.
RESULTS: Among 191 laboratory-prepared isolates in the analytical study, Xpert sensitivity for detection of rifampin resistance associated mutations was 97.7% and specificity was 90.8%, which increased to 99.0% after DNA sequencing analysis of the discordant samples. Of the 1,096 subjects in the four clinical studies, 49% were from the US. Overall, Xpert detected MTBc in 439 of 468 culture-positive specimens for a sensitivity of 93.8% (95% confidence interval [CI]: 91.2%-95.7%) and did not detect MTBc in 620 of 628 culture-negative specimens for a specificity of 98.7% (95% CI: 97.5%-99.4%). Sensitivity was 99.7% among smear-positive cases, and 76.1% among smear-negative cases. Non-determinate MTBc detection and false-positive RIF resistance results were low (1.2 and 0.9%, respectively).
CONCLUSIONS: The updated Xpert assay retained the high sensitivity and specificity of the previous assay versions and demonstrated low rates of non-determinate and RIF resistance false positive results
Latent Tuberculosis Infection in a Migrant Agricultural Community in Baja California, Mexico
The objectives were to estimate the prevalence and identify correlates of latent tuberculosis infection (LTBI) among residents of a migrant agricultural community in San Quintín, Baja-California, Mexico. Residents completed a questionnaire and had their blood tested for LTBI using the QuantiFERON®-TB Gold In-Tube (QFT) assay. Among 133 participants, 39.8% (95% CI 31.5–48.7%) tested QFT-positive. Having crossed the U.S.-Mexican border since living in San Quintin (P = 0.03), consuming unpasteurized milk (P = 0.02) and receiving health care at IMSS-Oportunidades in the last 6 months (P = 0.03) were independently associated with QFT-positivity. High LTBI prevalence in this community emphasizes the need for TB education and LTBI treatment for its residents. Association with travel to the U.S. suggests the potential for TB transmission across borders. Higher QFT-positivity among those consuming unpasteurized milk could indicate M. bovis infection, previously reported among Mexican migrants living in U.S. border cities
An assessment of factors associated with quality of randomized controlled trials for smoking cessation
To reduce smoking-related diseases, a research priority is to develop effective interventions for smoking cessation, and evidence from randomized controlled trials (RCTs) is usually considered to be the most valid. However, findings from RCTs may still be misleading due to methodological flaws. This study aims to assess the quality of 1083 RCTs of smoking cessation interventions in 41 relevant Cochrane Systematic Reviews (CSRs). Logistic regression analysis was performed to identify significant variables associated with the quality of RCTs. It was found that evidence for smoking cessation from RCTs was predominantly from high income countries, and the overall quality was high in only 8.6% of the RCTs. High quality RCTs tended to have a larger sample size, to be more recently published, and conducted in multiple countries belonging to different income categories. In conclusion, the overall quality of RCTs of smoking cessation interventions is far from perfect, and more RCTs in less developed countries are required to generate high grade evidence for global tobacco control. Collaboration between researchers in developed and less developed countries should be encouraged
Repeated administration of the GABAB receptor positive modulator BHF177 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine seeking in rats
Abstract: Rationale -Aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the brain and is implicated in the modulation of central reward processes. Acute or chronic administration of GABA receptor agonists or positive modulators decreased self-administration of various drugs of abuse. Furthermore, GABA receptor agonists inhibited cue-induced reinstatement of nicotine- and cocaine-seeking behavior. Because of their fewer adverse side effects compared with GABA receptor agonists, GABA receptor positive modulators are potentially improved therapeutic compounds for the treatment of drug dependence compared with agonists. Objectives and methods: We examined whether the acute effects of the GABA receptor positive modulator N-[(1R,2R,4S)-bicyclo[2.2.1]hept-2-yl]-2-methyl-5-[4-(trifluoromethyl)phenyl]-4-pyrimidinamine (BHF177) on nicotine self- administration and food-maintained responding under a fixed-ratio 5 schedule of reinforcement were maintained after repeated administration. The effects of acute BHF177 administration on cue-induced nicotine- and food-seeking behavior, a putative animal model of relapse, were also examined. Results: Repeated administration of BHF177 for 14 days decreased nicotine self-administration, with small tolerance observed during the last 7 days of treatment, whereas BHF177 minimally affected food-maintained responding. Acute BHF177 administration dose-dependently blocked cue-induced reinstatement of nicotine-, but not food-, seeking behavior after a 10-day extinction period. Conclusions: These results showed that BHF177 selectively blocked nicotine self-administration and prevented cueinduced reinstatement of nicotine seeking, with minimal effects on responding for food and no effect on cue-induced reinstatement of food seeking. Thus, GABA receptor positive modulators could be useful therapeutics for the treatment of different aspects of nicotine dependence by facilitating smoking cessation by decreasing nicotine intake and preventing relapse to smoking in humans
- …